Long-term treatment with 'Duovent' in elderly patients affected by chronic obstructive lung disease

Respiration. 1986:50 Suppl 2:245-8. doi: 10.1159/000195137.

Abstract

Twelve patients, aged over 60 years and suffering from chronic obstructive lung disease, were treated for 12 weeks with Duovent (fenoterol + ipratropium bromide). The clinical check-ups and indices of bronchial obstruction (FEV1, VC, RV, sGaw) were performed every 14 days. Improvement in symptoms corresponded to a significant improvement in the functional parameters. No negative cardiovascular effects, significant side-effects, or tolerance were seen after drug administration.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Atropine Derivatives / therapeutic use*
  • Clinical Trials as Topic
  • Drug Combinations / adverse effects
  • Drug Combinations / therapeutic use
  • Drug Tolerance
  • Female
  • Fenoterol / adverse effects
  • Fenoterol / therapeutic use*
  • Forced Expiratory Volume
  • Heart Rate / drug effects
  • Humans
  • Ipratropium / adverse effects
  • Ipratropium / therapeutic use*
  • Lung Diseases, Obstructive / drug therapy*
  • Male
  • Middle Aged
  • Residual Volume
  • Time Factors
  • Vital Capacity

Substances

  • Atropine Derivatives
  • Drug Combinations
  • fenoterol, ipratropium drug combination
  • Fenoterol
  • Ipratropium